Ed and Ethel Moore Alzheimer’s Disease Research Program
Ed and Ethel Moore Alzheimer’s Disease Research Program supports Florida researchers through studies, consortia, and fellowships to advance Alzheimer’s prevention, diagnosis, treatment, care, and potential cures.
Funder: Florida Ed and Ethel Moore Alzheimer's Disease Research Program
Due Dates: September 29, 2026, 11:59 PM (Questions) | October 2, 2026 (Q&A posting) | October 20, 2026, noon ET (Applications)
Funding Amounts: Consortium: up to $750,000 over 48 months; Standard: up to $350,000 over 48 months; Pilot and Postdoctoral Fellowship: up to $100,000 over 24 months
Summary: Supports Florida-based Alzheimer’s research advancing prevention, diagnosis, treatment, care management, and potential cures.
Key Information: The corresponding PI must be an applicant employee and a U.S. citizen or permanent resident.
Description
Administered by the Florida Department of Health’s Biomedical Research Section, this program funds Alzheimer’s disease research intended to deliver meaningful benefits to Floridians. Its legislative goals are to improve health, expand knowledge of Alzheimer’s prevention, diagnosis, treatment, and cure, and stimulate related economic activity in Florida. Priority is given to research designed to prevent or cure the disease.
The fiscal year 2026–2027 competition supports exploratory pilot studies, fully developed research, statewide consortia, and postdoctoral research fellowship training. Proposals must address one of five priorities: behavioral and social needs of people with Alzheimer’s and caregivers; therapeutic targets, mechanisms, and biomarkers; broader clinical research through consortia; epidemiology relevant to Florida’s population; or clinical, patient-oriented fellowship training. Consortium grants are encouraged, and research infrastructure applications with exceptional scientific merit may receive preferential funding.
